✦ LIBER ✦

Expression of the c-Kit receptor and its ligand SCF in non-small-cell lung carcinomas

✍ Scribed by Torsten Pietsch; Maria Rita Nicotra; Rocco Fraioli; Helmut Karl Wolf; Marcella Mottolese; Pier Giorgio Natali

Publisher: John Wiley and Sons
Year: 1998
Tongue: French
Weight: 247 KB
Volume: 75
Category: Article
ISSN: 0020-7136
DOI: 10.1002/(sici)1097-0215(19980119)75:2<171::aid-ijc1>3.0.co;2-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etoposide in the management of non-small

Etoposide in the management of non-small cell lung cancer

✍ John C. Ruckdeschel 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB 👁 2 views

Investigation of the genes for RET and i

Investigation of the genes for RET and its ligand complex, GDNF/GFRα-1, in small cell lung carcinoma

✍ Lois M. Mulligan; Tineke Timmer; Stacey M. Ivanchuk; Barbara G. Campling; Leah C 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 1 views

RET is a receptor tyrosine kinase expressed in neuroendocrine cells and in tumors of these cell types. RET activation may be mediated by a ligand complex comprising glial cell line-derived neurotrophic factor (GDNF) and GDNF family receptor alpha-1 (GFR␣-1). Activating RET mutations are found in the

Cisplatin, etoposide, and mitomycin in t

Cisplatin, etoposide, and mitomycin in the treatment of non-small cell carcinoma of the lung. A pilot study

✍ Stephen Davis; Maurizio Tomato; Lucio Crino; Mari Antonetta Colozza; Kenneth Lub 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 2 views

A total of 39 patients with non-small cell carcinoma of the lung (NSCL) were treated with cisplatin, etoposide, and mitomycin. A major response rate (complete response + partial response) was seen in 15 patients (39%). Median survival for all patients was 340 days; median survival of the responding

Analysis of T-cell-receptor β-chain-gene

Analysis of T-cell-receptor β-chain-gene usage in peripheral-blood and tumor-infiltrating lymphocytes from human non-small-cell lung carcinomas

✍ Hamid Echchakir; Carine Asselin-Paturel; Guillaume Dorothee; Isabelle Vergnon; D 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 187 KB 👁 1 views

Non-small-cell lung cancers (NSCLC) are often infiltrated by T lymphocytes. It is postulated that the presence of tumor-infiltrating lymphocytes (TIL) reflects a local host immune response against autologous tumors. To identify the nature of NSCLC TIL, we have characterized the molecular structure o

Significance of autocrine motility facto

Significance of autocrine motility factor receptor gene expression as a prognostic factor in non-small-cell lung cancer

✍ Iwao Takanami; Ken Takeuchi; Hideomi Watanabe; Takashi Yanagawa; Kenji Takagishi 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 220 KB 👁 2 views

Evidence for a role of FGF-2 and FGF rec

Evidence for a role of FGF-2 and FGF receptors in the proliferation of non-small cell lung cancer cells

✍ Walter Berger; Ulrike Setinek; Thomas Mohr; Ingela Kindas-Mügge; Monika Vetterle 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 375 KB 👁 2 views

Basic fibroblast growth factor (FGF-2) has been implicated in the progression of human tumours via both autocrine and paracrine (angiogenic) activities. We investigated the expression of FGF-2 and FGF receptors (FGFR-1 to -4) in NSCLC cell lines (N ‫؍‬ 16), NSCLC surgical specimens (N ‫؍‬ 21) and 2